AUPQ869900A0 - Novel therapeutic molecular variants and uses thereof - ii - Google Patents
Novel therapeutic molecular variants and uses thereof - iiInfo
- Publication number
- AUPQ869900A0 AUPQ869900A0 AUPQ8699A AUPQ869900A AUPQ869900A0 AU PQ869900 A0 AUPQ869900 A0 AU PQ869900A0 AU PQ8699 A AUPQ8699 A AU PQ8699A AU PQ869900 A AUPQ869900 A AU PQ869900A AU PQ869900 A0 AUPQ869900 A0 AU PQ869900A0
- Authority
- AU
- Australia
- Prior art keywords
- novel therapeutic
- molecular variants
- therapeutic molecular
- variants
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ8699A AUPQ869900A0 (en) | 2000-07-11 | 2000-07-11 | Novel therapeutic molecular variants and uses thereof - ii |
NZ523343A NZ523343A (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
EP01942904A EP1299548A4 (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
US10/312,336 US20080279841A1 (en) | 2000-06-28 | 2001-06-20 | Novel Therapeutic Molecular Variants And Uses Thereof |
BR0112059-0A BR0112059A (en) | 2000-06-28 | 2001-06-20 | Enphytosine kinase variant, isolated nucleic acid molecule, methods of detecting an agent capable of modulating the interaction of fosk with sphingosine kinase and an agent capable of binding or differently associating with the amino acid defined sphingosine kinase region 16-153 for the analysis, projection and / or modification of an agent capable of interacting with the sphingosine kinase region defined by amino acids 16-153 and modulating at least one functional activity associated with said sphingosine kinase cellular functional activity in a mammal and treatment and / or prophylaxis of a condition in a mammal, agent, use of a sphingosine kinase variant, and pharmaceutical composition |
MXPA02012924A MXPA02012924A (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof. |
AU6569901A AU6569901A (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
CN01813405A CN1444654A (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
IL15365301A IL153653A0 (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
PCT/AU2001/000730 WO2002000887A1 (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
JP2002506202A JP2004500903A (en) | 2000-06-28 | 2001-06-20 | Therapeutic molecular variants and methods of use |
CA002414210A CA2414210A1 (en) | 2000-06-28 | 2001-06-20 | Novel therapeutic molecular variants and uses thereof |
NO20026265A NO20026265L (en) | 2000-06-28 | 2002-12-27 | New therapeutic molecular variants, and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ8699A AUPQ869900A0 (en) | 2000-07-11 | 2000-07-11 | Novel therapeutic molecular variants and uses thereof - ii |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPQ869900A0 true AUPQ869900A0 (en) | 2000-08-03 |
Family
ID=3822763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPQ8699A Abandoned AUPQ869900A0 (en) | 2000-06-28 | 2000-07-11 | Novel therapeutic molecular variants and uses thereof - ii |
Country Status (1)
Country | Link |
---|---|
AU (1) | AUPQ869900A0 (en) |
-
2000
- 2000-07-11 AU AUPQ8699A patent/AUPQ869900A0/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
AU2002311794A1 (en) | Modular molecular clasps and uses thereof | |
AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
AU715620C (en) | Therapeutic methods and uses | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2001243515A1 (en) | Combination drug therapy | |
AU2001229439A1 (en) | Bioconjugates and uses thereof | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU2001232244A1 (en) | Drug comprising combination | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AUPQ884500A0 (en) | Novel therapeutic molecules and uses therefor - III | |
IL153653A0 (en) | Novel therapeutic molecular variants and uses thereof | |
AUPQ998000A0 (en) | Novel therapeutic molecular variants and uses thereof-iii | |
AUPQ869900A0 (en) | Novel therapeutic molecular variants and uses thereof - ii | |
AUPQ840800A0 (en) | Novel therapeutic molecular variants and uses thereof | |
AU2001231141A1 (en) | Novel human septin and uses thereof | |
AU2001292897A1 (en) | Novel therapy | |
AUPR274901A0 (en) | Novel therapeutic molecular variants and uses thereof - IV | |
AU6569901A (en) | Novel therapeutic molecular variants and uses thereof | |
AUPR073000A0 (en) | Novel therapeutic molecules and uses therefor - iv | |
AUPQ884200A0 (en) | Novel therapeutic molecules and uses therefor - I | |
AUPR073100A0 (en) | Novel therapeutic molecules and uses therefor - vii | |
AUPR073200A0 (en) | Novel therapeutic molecules and uses therefor - VI |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 6569901 Country of ref document: AU |